RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA

Clinical trials for RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy tested to boost stomach cancer fight before surgery

Disease control Recruiting now

This early-stage trial is testing whether combining a newer immunotherapy drug (tislelizumab) with standard chemotherapy (FLOT) is safe and tolerable when given before surgery for certain stomach and esophagus cancers. The goal is to see if giving more chemotherapy before surgery…

Matched conditions: RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA

Get alerted when new RESECTABLE ESOPHAGOGASTRIC ADENOCARCINOMA trials appear

New combo therapy tested to boost stomach cancer fight before surgery